Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male Volunteers

NCT01214109 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: pramipexole extended release
DRUG: pramipexole extended release
DRUG: pramipexole immediate release
DRUG: pramipexole immediate release

Sponsor

Boehringer Ingelheim